img source: adobeimages
With millions of Americans suffering from chronic pain, new treatments and strategies to help lessen pain symptoms are of significant importance. Recently, a study at Northwestern University has combined two FDA-approved drugs, targeting the nucleus accumbens, a brain region responsible for emotions and addiction. One L-dopa drug used for Parkinson’s patients and one non-steroidal anti-inflammatory are administered together in rodents to eliminate chronic pain behavior. This combination raises dopamine levels to more effectively treat chronic pain, the number one cause of disability in the U.S. right now.